You have accessRestricted access
Activation of the TLR2-MyD88 pathway is required for in-vivo efficacy of Lipid Nanoparticle based vaccine formulation
Gokul Swaminathan, Shu-An Lin, ManishKumar Patel, Katie DiFelice, Jeffrey Smith, Marian Gindy, Ashley Mahne, Daniel Cua, Danilo Casimiro, Amy Espeseth and Andrew Bett
J Immunol 198 (1 Supplement) 79.2; May 1, 2017,
